224 related articles for article (PubMed ID: 37298547)
1. Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease.
Rubino V; Carriero F; Palatucci AT; Giovazzino A; Leone S; Nicolella V; Calabrò M; Montanaro R; Brancaleone V; Pane F; Chiurazzi F; Ruggiero G; Terrazzano G
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298547
[TBL] [Abstract][Full Text] [Related]
2. The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL).
Junevik K; Werlenius O; Hasselblom S; Jacobsson S; Nilsson-Ehle H; Andersson PO
Ann Hematol; 2007 Feb; 86(2):89-94. PubMed ID: 17043777
[TBL] [Abstract][Full Text] [Related]
3. In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids.
Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
Clin Exp Immunol; 2003 Jan; 131(1):82-9. PubMed ID: 12519390
[TBL] [Abstract][Full Text] [Related]
4. Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia.
Foa R; Lauria F; Lusso P; Giubellino MC; Fierro MT; Ferrando ML; Raspadori D; Matera L
Br J Haematol; 1984 Nov; 58(3):509-16. PubMed ID: 6333890
[TBL] [Abstract][Full Text] [Related]
5. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy.
Hoogendoorn M; Wolbers JO; Smit WM; Schaafsma MR; Barge RM; Willemze R; Falkenburg JH
Leukemia; 2004 Jul; 18(7):1278-87. PubMed ID: 15116118
[TBL] [Abstract][Full Text] [Related]
6. Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate.
Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
Clin Exp Immunol; 2001 Oct; 126(1):16-28. PubMed ID: 11678895
[TBL] [Abstract][Full Text] [Related]
7. Reduced expansion of CD94/NKG2C
Puiggros A; Blanco G; Muntasell A; Rodríguez-Rivera M; Nonell L; Altadill M; Puigdecanet E; Arnal M; Calvo X; Gimeno E; Abella E; Abrisqueta P; Bosch F; Yélamos J; Ferrer A; López-Botet M; Espinet B
Int J Lab Hematol; 2021 Oct; 43(5):1032-1040. PubMed ID: 33615729
[TBL] [Abstract][Full Text] [Related]
8. Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotic tumor lysate.
Suresh K; Fraser G; Scheid E; Leber B; Gauldie J; Foley R
Leuk Lymphoma; 2006 Feb; 47(2):297-306. PubMed ID: 16321861
[TBL] [Abstract][Full Text] [Related]
9. B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytes.
Matera L; Foa R; Massaia M; Giovarelli M; Veglia F; Cesano A; Lusso P; Piazza A; Santoli D
J Clin Immunol; 1989 Jul; 9(4):329-37. PubMed ID: 2475521
[TBL] [Abstract][Full Text] [Related]
10. B cell chronic lymphocytic leukaemia cells have reduced capacity to upregulate expression of MHC class I in response to interferon-gamma.
Juffs H; Fowler N; Saal R; Grimmett K; Beasley S; O'Sullivan B; Frazer I; Gill D; Thomas R
Pathology; 2004 Feb; 36(1):69-76. PubMed ID: 14757560
[TBL] [Abstract][Full Text] [Related]
11. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G.
Maki G; Hayes GM; Naji A; Tyler T; Carosella ED; Rouas-Freiss N; Gregory SA
Leukemia; 2008 May; 22(5):998-1006. PubMed ID: 18288133
[TBL] [Abstract][Full Text] [Related]
12. Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells.
Wallgren A; Festin R; Gidlöf C; Dohlsten M; Kalland T; Tötterman TH
Blood; 1993 Aug; 82(4):1230-8. PubMed ID: 8102559
[TBL] [Abstract][Full Text] [Related]
13. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
14. Specific features of T- and NK-cellular immunity in chronic lymphocytic leukemia.
Pochtar EV; Lugovskaya SA; Naumova EV; Dmitrieva EA; Kostin AI; Dolgov VV
Klin Lab Diagn; 2021 Jun; 66(6):345-352. PubMed ID: 34105910
[TBL] [Abstract][Full Text] [Related]
15. HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia.
Wagner B; da Silva Nardi F; Schramm S; Kraemer T; Celik AA; Dürig J; Horn PA; Dührsen U; Nückel H; Rebmann V
Cancer; 2017 Mar; 123(5):814-823. PubMed ID: 27859015
[TBL] [Abstract][Full Text] [Related]
16. Redirection of CMV-specific CTL towards B-CLL via CD20-targeted HLA/CMV complexes.
Mous R; Savage P; Remmerswaal EB; van Lier RA; Eldering E; van Oers MH
Leukemia; 2006 Jun; 20(6):1096-102. PubMed ID: 16557240
[TBL] [Abstract][Full Text] [Related]
17. NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.
Sportoletti P; De Falco F; Del Papa B; Baldoni S; Guarente V; Marra A; Dorillo E; Rompietti C; Adamo FM; Ruggeri L; Di Ianni M; Rosati E
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206399
[TBL] [Abstract][Full Text] [Related]
18. HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications.
Rebmann V; Nückel H; Dührsen U; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):430-5. PubMed ID: 17683947
[TBL] [Abstract][Full Text] [Related]
19. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).
Porakishvili N; Roschupkina T; Kalber T; Jewell AP; Patterson K; Yong K; Lydyard PM
Clin Exp Immunol; 2001 Oct; 126(1):29-36. PubMed ID: 11678896
[TBL] [Abstract][Full Text] [Related]
20. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
Buhmann R; Nolte A; Westhaus D; Emmerich B; Hallek M
Blood; 1999 Mar; 93(6):1992-2002. PubMed ID: 10068672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
